NEA Management Company as of March 31, 2019
Portfolio Holdings for NEA Management Company
NEA Management Company holds 45 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Elastic N V ord (ESTC) | 23.1 | $444M | 5.6M | 79.90 | |
| Ra Pharmaceuticals | 7.1 | $138M | 6.1M | 22.40 | |
| Rhythm Pharmaceuticals (RYTM) | 7.0 | $135M | 4.9M | 27.41 | |
| Glycomimetics (GLYC) | 5.9 | $113M | 9.1M | 12.46 | |
| Allakos (ALLK) | 4.8 | $92M | 2.3M | 40.50 | |
| Epizyme | 4.4 | $85M | 6.9M | 12.39 | |
| Senseonics Hldgs (SENS) | 3.9 | $76M | 31M | 2.45 | |
| Crispr Therapeutics (CRSP) | 3.9 | $75M | 2.1M | 35.72 | |
| Clementia | 3.7 | $71M | 2.7M | 26.10 | |
| Adaptimmune Therapeutics (ADAP) | 3.5 | $68M | 16M | 4.30 | |
| Mersana Therapeutics (MRSN) | 3.2 | $63M | 12M | 5.26 | |
| Obseva Sa | 3.0 | $59M | 4.6M | 12.79 | |
| Dermira | 2.5 | $48M | 3.5M | 13.55 | |
| Ardelyx (ARDX) | 2.2 | $43M | 15M | 2.80 | |
| Aurinia Pharmaceuticals (AUPH) | 1.8 | $34M | 5.2M | 6.50 | |
| Marker Therapeutics Ord | 1.7 | $33M | 5.0M | 6.60 | |
| Synlogic | 1.7 | $32M | 4.2M | 7.59 | |
| Nightstar Therapeutics | 1.6 | $31M | 1.2M | 25.37 | |
| Liquidia Technologies (LQDA) | 1.5 | $28M | 2.5M | 11.38 | |
| Millendo Therapeutics | 1.4 | $27M | 1.8M | 15.00 | |
| Affimed Therapeutics B V | 1.1 | $22M | 5.1M | 4.20 | |
| Genocea Biosciences | 1.1 | $21M | 35M | 0.59 | |
| Strongbridge Bioph shs usd | 1.1 | $21M | 4.1M | 4.98 | |
| Mei Pharma | 0.9 | $18M | 5.7M | 3.07 | |
| AVEO Pharmaceuticals | 0.9 | $17M | 21M | 0.82 | |
| Surface Oncology | 0.8 | $16M | 3.3M | 4.77 | |
| Champions Oncology (CSBR) | 0.8 | $15M | 1.6M | 9.79 | |
| Lexicon Pharmaceuticals (LXRX) | 0.7 | $13M | 2.4M | 5.56 | |
| ArQule | 0.6 | $12M | 2.5M | 4.79 | |
| Bloom Energy Corp (BE) | 0.6 | $12M | 1.3M | 9.17 | |
| Dasan Zhone Solutions | 0.5 | $10M | 956k | 10.69 | |
| Rigel Pharmaceuticals | 0.4 | $8.3M | 3.2M | 2.57 | |
| Verona Pharma Plc ads (VRNA) | 0.4 | $7.9M | 1.2M | 6.50 | |
| Proteostasis Therapeutics In | 0.4 | $7.0M | 5.6M | 1.26 | |
| Trevena | 0.3 | $5.9M | 3.8M | 1.56 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $5.8M | 333k | 17.41 | |
| Tracon Pharmaceuticals | 0.2 | $4.8M | 3.5M | 1.37 | |
| Erytech Pharma Sa | 0.2 | $4.7M | 625k | 7.58 | |
| Cti Biopharma | 0.2 | $3.6M | 3.8M | 0.97 | |
| Achaogen | 0.1 | $2.3M | 5.2M | 0.45 | |
| Endologix | 0.1 | $1.6M | 249k | 6.61 | |
| Akari Therapeutics | 0.1 | $1.6M | 452k | 3.58 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $1.6M | 1.3M | 1.22 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $1.4M | 2.1M | 0.66 | |
| Regulus Therapeutics | 0.1 | $934k | 916k | 1.02 |
